Study protocol: Effectiveness of dual-mobility cups compared with uni-polar cups for preventing dislocation after primary total hip arthroplasty in elderly patients - design of a randomized controlled trial nested in the Dutch Arthroplasty Registry.


Journal

Acta orthopaedica
ISSN: 1745-3682
Titre abrégé: Acta Orthop
Pays: Sweden
ID NLM: 101231512

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 5 8 2020
medline: 15 1 2021
entrez: 5 8 2020
Statut: ppublish

Résumé

Background and purpose - Dislocation is the leading reason for early revision surgery after total hip arthroplasty (THA). The dual-mobility (DM) cup was developed to provide more stability and mechanically reduce the risk of dislocation. Despite the increased use of DM cups, high-quality evidence of their (cost-)effectiveness is lacking. The primary objective of this randomized controlled trial (RCT) is to investigate whether there is a difference in the number of hip dislocations following primary THA, using the posterolateral approach, with a DM cup compared with a unipolar (UP) cup in elderly patients 1 year after surgery. Secondary outcomes include the number of revision surgeries, patient-reported outcome measures (PROMs), and cost-effectiveness.Methods and analysis - This is a prospective multicenter nationwide, single-blinded RCT nested in the Dutch Arthroplasty Registry. Patients ≥ 70 years old, undergoing elective primary THA using the posterolateral approach, will be eligible. After written informed consent, 1,100 participants will be randomly allocated to the intervention or control group. The intervention group receives a THA with a DM cup and the control group a THA with a UP cup. PROMs are collected preoperatively, and 3 months, 1 and 2 years postoperatively. Primary outcome is the difference in number of dislocations between the UP and DM cup within 1 year, reported in the registry (revisions), or by the patients (closed or open reduction). Data will be analyzed using multilevel models as appropriate for each outcome (linear/logistic/survival). An economic evaluation will be performed from the healthcare and societal perspective, for dislocation and quality adjusted life years (QALYs).Trial registration - This RCT is registered at www.clinicaltrials.gov with identification number NCT04031820.

Identifiants

pubmed: 32746668
doi: 10.1080/17453674.2020.1798658
pmc: PMC8023924
doi:

Banques de données

ClinicalTrials.gov
['NCT04031820']

Types de publication

Clinical Trial Protocol Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

514-519

Investigateurs

E Scheijbeler (E)
D H R Kempen (DHR)
W P Zijlstra (WP)
B Dijkstra (B)
H B Ettema (HB)
M J Q Steinweg (MJQ)
J L C van Susante (JLC)
L D de Jong (LD)
A de Gast (A)
J Bekkers (J)
M van Dijk (M)
N Wolterbeek (N)
T D Berendes (TD)
T Gosens (T)
W van der Weegen (W)

Références

Orthop Traumatol Surg Res. 2016 Apr;102(2):143-8
pubmed: 26803224
Clin Orthop Relat Res. 2006 Jun;447:9-18
pubmed: 16672897
J Arthroplasty. 2017 Jul;32(7):2088-2092
pubmed: 28336249
Eur J Orthop Surg Traumatol. 2013 May;23(4):425-9
pubmed: 23412297
Int Orthop. 2017 Mar;41(3):475-480
pubmed: 27826763
Int Orthop. 2009 Aug;33(4):927-32
pubmed: 18521598
J Arthroplasty. 2019 Dec;34(12):2983-2991
pubmed: 31444020
J Bone Joint Surg Am. 2009 Jan;91(1):128-33
pubmed: 19122087
J Bone Joint Surg Am. 2003 Jan;85(1):20-6
pubmed: 12533567
Clin Orthop Relat Res. 2013 Feb;471(2):439-43
pubmed: 22576929
J Bone Joint Surg Am. 1982 Dec;64(9):1295-306
pubmed: 7142237
Surg Technol Int. 2018 Jun 1;32:331-336
pubmed: 29689589
Int Orthop. 2012 Mar;36(3):511-8
pubmed: 21698430
J Arthroplasty. 2010 Sep;25(6 Suppl):21-5
pubmed: 20541885
Clin Orthop Relat Res. 2008 Feb;466(2):389-95
pubmed: 18196422
Ned Tijdschr Geneeskd. 2003 Feb 15;147(7):286-90
pubmed: 12622005
Orthop Traumatol Surg Res. 2020 May;106(3):509-517
pubmed: 32278733
Int Orthop. 2014 Jun;38(6):1125-9
pubmed: 24737147
Acta Orthop. 2012 Oct;83(5):442-8
pubmed: 23039167
Bone Joint J. 2017 Jan;99-B(ASuppl1):18-24
pubmed: 28042114
Bone Joint J. 2015 Aug;97-B(8):1046-9
pubmed: 26224819
Int Orthop. 2017 Mar;41(3):645-659
pubmed: 28004142
Cochrane Database Syst Rev. 2004;(1):CD003828
pubmed: 14974039
J Orthop Surg Res. 2019 Nov 21;14(1):376
pubmed: 31752951
J Arthroplasty. 2016 Sep;31(9):1970-8
pubmed: 27006147
J Arthroplasty. 2004 Jun;19(4 Suppl 1):111-4
pubmed: 15190564
Orthop Traumatol Surg Res. 2009 Oct;95(6):407-13
pubmed: 19656750
Hip Int. 2018 Mar;28(2):161-167
pubmed: 28967056
Int Orthop. 2017 Mar;41(3):605-610
pubmed: 27888294
Bone Joint J. 2018 Jan;100-B(1):11-19
pubmed: 29305445
Int Orthop. 2020 Feb;44(2):253-260
pubmed: 31758218
Dtsch Arztebl Int. 2014 Dec 22;111(51-52):884-90
pubmed: 25597367
Arthroplast Today. 2017 Feb 05;3(3):197-202
pubmed: 28913407
Osteoarthritis Cartilage. 2007 Jan;15(1):104-9
pubmed: 16890460
Int Orthop. 2017 Mar;41(3):595-598
pubmed: 28078363
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Acta Orthop. 2019 Feb;90(1):11-14
pubmed: 30451041
Int Orthop. 2013 Dec;37(12):2345-50
pubmed: 24026216
J Bone Joint Surg Am. 2006 Feb;88(2):290-4
pubmed: 16452739
Qual Life Res. 2009 Nov;18(9):1177-84
pubmed: 19714486

Auteurs

Bart C H Van Der Wal (BCH)

University Medical Center Utrecht, Utrecht.

Dirk Jan F Moojen (DJF)

OLVG, Amsterdam.

Marieke F Van Wier (MF)

OLVG, Amsterdam.

Amanda D Klaassen (AD)

OLVG, Amsterdam.

Rudolf W Poolman (RW)

OLVG, Amsterdam.
LUMC, Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH